StockWatch
·
Biotechnology: Electromedical & Electrotherapeutic Apparatus
RegulatoryOct 1, 2026, 05:01 PM

Nexalin Technology Regains Nasdaq Bid Price Compliance; Faces Equity Hurdle

AI Summary

Nexalin Technology, Inc. announced it has received formal notification from Nasdaq confirming it has regained compliance with the minimum bid price requirement of $1.00 per share. The company was previously granted an exception to continue listing, subject to demonstrating compliance with the minimum stockholders' equity requirement of $2,500,000 by January 4, 2027. Nexalin intends to meet this requirement and its stock will continue trading on Nasdaq during the exception period, though failure to comply could lead to delisting.

Key Highlights

  • Nexalin Technology regained compliance with Nasdaq's minimum bid price requirement of $1.00.
  • The company must demonstrate compliance with the minimum stockholders' equity requirement of $2,500,000 by January 4, 2027.
  • The company's common stock will continue to be listed on Nasdaq during the exception period.